Future of the PCI Readmission Metric

Circulation. Cardiovascular Quality and Outcomes
Jason H Wasfy, Robert W Yeh

Abstract

Between 2013 and 2014, the Centers for Medicare and Medicaid Services and the National Cardiovascular Data Registry publically reported risk-adjusted 30-day readmission rates after percutaneous coronary intervention (PCI) as a pilot project. A key strength of this public reporting effort included risk adjustment with clinical rather than administrative data. Furthermore, because readmission after PCI is common, expensive, and preventable, this metric has substantial potential to improve quality and value in American cardiology care. Despite this, concerns about the metric exist. For example, few PCI readmissions are caused by procedural complications, limiting the extent to which improved procedural technique can reduce readmissions. Also, similar to other readmission measures, PCI readmission is associated with socioeconomic status and race. Accordingly, the metric may unfairly penalize hospitals that care for underserved patients. Perhaps in the context of these limitations, Centers for Medicare and Medicaid Services has not yet included PCI readmission among metrics that determine Medicare financial penalties. Nevertheless, provider organizations may still wish to focus on this metric to improve value for cardiology patients...Continue Reading

References

Jul 4, 2007·Health Promotion Practice·Justin G TrogdonDiane Orenstein
Jan 26, 2011·Circulation·Paul A HeidenreichUNKNOWN Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research
Dec 24, 2011·JACC. Cardiovascular Interventions·Edward L HannanSpencer B King
Dec 30, 2011·The New England Journal of Medicine·Elliott S FisherDana G Safran
Mar 23, 2012·Circulation. Cardiovascular Interventions·Robert W YehSharon-Lise T Normand
Mar 30, 2012·The New England Journal of Medicine·Karen E Joynt, Ashish K Jha
Apr 13, 2012·The New England Journal of Medicine·Zirui Song, Bruce E Landon
Mar 23, 2013·JACC. Cardiovascular Interventions·Gregory W YostJames C Blankenship
Jul 4, 2013·Circulation. Cardiovascular Quality and Outcomes·Jason H WasfyRobert W Yeh
Jan 16, 2014·Circulation. Cardiovascular Interventions·Jason H WasfyRobert W Yeh
Aug 12, 2014·Journal of Cardiovascular Medicine·Claudio MorettiFiorenzo Gaita
Sep 28, 2014·Journal of the American Heart Association·Jason H WasfyRobert W Yeh
Feb 11, 2015·BMJ : British Medical Journal·Leora I HorwitzJoseph S Ross
Feb 14, 2015·Science·Yael Politi, James C Weaver
Mar 5, 2015·Circulation. Cardiovascular Quality and Outcomes·Oluseyi Ojeifo, Scott A Berkowitz
Sep 15, 2015·JAMA Internal Medicine·Michael L BarnettJ Michael McWilliams
Oct 28, 2015·JAMA : the Journal of the American Medical Association·Ashish K Jha
Nov 1, 2015·European Heart Journal. Quality of Care & Clinical Outcomes·Claudio MorettiFiorenzo Gaita

❮ Previous
Next ❯

Citations

Sep 7, 2016·American Heart Journal·Varsha K Tanguturi, Jason H Wasfy
Aug 25, 2016·Circulation. Cardiovascular Quality and Outcomes·Varsha K TanguturiJason H Wasfy
Dec 17, 2017·Circulation. Cardiovascular Interventions·Jordan B Strom, Robert W Yeh
Feb 17, 2018·Circulation. Cardiovascular Quality and Outcomes·Brahmajee K Nallamothu, P Michael Ho
Jun 6, 2019·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Byomesh TripathiSaurav Chatterjee
May 11, 2017·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Jorge A Belardi, Mariano Albertal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Ashish K JhaArnold M Epstein
Circulation. Cardiovascular Interventions
Jason H WasfyRobert W Yeh
Journal of Community Hospital Internal Medicine Perspectives
Rohit Gulati
© 2021 Meta ULC. All rights reserved